ClinicalTrialsFinder

Carcinoma, Non-Small Cell Lung Clinical Trials in Passo Fundo, Rio Grande do Sul

1 recruitingPasso Fundo, Rio Grande do Sul, Brazil

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Carcinoma, Non-Small Cell Lung
Merck Sharp & Dohme LLC680 enrolled225 locationsNCT06623422